Document is current
Any future updates will be listed below
-
Authors
Katz, Liora S. https://orcid.org/0000-0002-3097-0767
Visser, Emira J.
Plitzko, Kathrin F.
Pennings, Marloes A. M. https://orcid.org/0000-0002-3366-0238
Cossar, Peter J. https://orcid.org/0000-0002-8260-5710
Tse, Isabelle L.
Kaiser, Markus https://orcid.org/0000-0002-6540-8520
Brunsveld, Luc https://orcid.org/0000-0001-5675-511X
Ottmann, Christian https://orcid.org/0000-0001-7315-0315
Scott, Donald K. https://orcid.org/0000-0002-1414-9223
- License Information
-
More Information
Article History
Received: 11 April 2024
Accepted: 17 February 2025
First Online: 2 March 2025
Competing interests
: US provisional patent application No. 63/523,289—Pennings M.A.M., Katz L.S. Ottmann C., Scott D.K., Visser E.J., Plitzko K.F., Kaiser M., Cossar P.J., Brunsveld L. Small-molecule stabilizers of the ChREBP–14-3-3 interaction with cellular activity. United States Patent and Trademark Office, June 2023. The authors declare the following competing financial interest(s): L.B. and C.O. are founders of Ambagon Therapeutics. L.B. is a member of Ambagon’s scientific advisory board, C.O. is employee of Ambagon. All other Authors declare no competing interests.
